Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
In this study, the investigators test 2 dose levels of thiotepa (5 mg/kg and 10 mg/kg) added to the backbone of targeted reduced dose IV busulfan, fludarabine and rabbit anti-thymocyte globulin (rATG) to determine the minimum effective dose required for reliable engraftment for subjects undergoing hematopoietic stem cell transplantation for non-malignant disease.
Epistemonikos ID: ef4001cd8a1a4826768f5db9b37ea3b0ad0b0b35
First added on: Feb 06, 2024